Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Revenue

Wuhan Easy Diagnosis Biomedicine had revenue of 71.35M CNY in the quarter ending September 30, 2024, a decrease of -19.26%. This brings the company's revenue in the last twelve months to 349.23M, down -90.53% year-over-year. In the year 2023, Wuhan Easy Diagnosis Biomedicine had annual revenue of 749.54M, down -92.88%.

• Revenue (ttm): 349.23M
• Revenue Growth: -90.53%
• P/S Ratio: 11.12
• Revenue / Employee: 328.53K
• Employees: 1,063
• Market Cap: 3.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	749.54M	-9.78B	-92.88%
Jan 1, 2023	10.53B	7.70B	272.12%
Jan 1, 2022	2.83B	1.87B	195.05%
Dec 31, 2020	959.10M	777.94M	429.43%
Dec 31, 2019	181.16M	4.77M	2.71%